PharmiWeb.com - Global Pharma News & Resources
20-Apr-2019

Antihypertensive Drugs Market expected to show Sluggish Growth Rate 3.1% by 2023 in Worldwide Market

Global Antihypertensive Drugs Market is projected to showcase approximately sluggish CAGR of around 3.1%during the forecast period till 2023.

Antihypertensive Drugs Market Research Report: by Therapeutic Class (Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others), by Type (Primary Hypertension, Secondary Hypertension), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites amp; Online Drug Stores, Others), and Region - Global Forecast till 2023

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/11960

Market analysis

Antihypertensive medications are prescribed by reputed clinicians for the management of hypertension or high blood pressure. The high pervasiveness of hypertension is the essential driver of the global antihypertensive medications market. Several awareness campaigns by several government and non-profit associations are probably going to work for the market. For example, the Pulmonary Hypertension Association (PHA) offers training programs and has a solid encouraging group of people which offers patients the right information about the treatment. The rising predominance of incessant illnesses is powering the interest of antihypertensive drugs or medications. What's more, the section of generics which has cut down patient expenses is anticipated to look good for the market over the forecast period (2018- 2023). The market is expected to grow at 3.1% CAGR during the forecast period.

Market segmentation

Based on its therapeutic classes, the global antihypertensive drugs market is segmented into beta-adrenergic blockers, calcium channel blockers, renin inhibitors, vasodilators, angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, diuretics, and others. On the basis of its type, the market is bifurcated into secondary and primary hypertension. Lastly, on the basis of its distribution channels, the market is bifurcated into hospital pharmacy, e-commerce websites and online drug stores, retail pharmacy, and others.

Regional analysis

Geographically, the global antihypertensive drugs market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Merck KGaA (Germany), Johnson amp; Johnson Services, Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), and United Therapeutics Corporation (U.S.), Sanofi S.A. (France), Novartis AG (Switzerland), AstraZeneca (U.K.), Daiichi Sankyo Company, Ltd. (Japan), Boehringer Engelheim GmbH (Germany), Takeda Pharmaceutical Company (Japan), among others are some of the major players in the global antihypertensive drugs market.

Few Significant Points From Table Of Contents:

Global Antihypertensive Drugs Market Research Report Forecast to 2023

1 Report Prologue
2 Executive Summary
3 Market Introduction
4 Research Methodology
5 Market Dynamics
6 Market Factor Analysis
7 Global Antihypertensive Drugs Market, by Therapeutic Class
8 Global Antihypertensive Drugs Market, by Type
9 Global Antihypertensive Drugs Market, by Distribution Channel
10 Global Antihypertensive Drugs Market, by Region
11 Competitive Landscape
12 Company Profile
13 Appendix

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11960

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

For More Pharma amp; Healthcare Related Reports@ Pharma amp; Healthcare

Editor Details

Last Updated: 20-Apr-2019